Healthcare Cold Chain Logistics Market - Global Outlook & Forecast 2023-2028

339 pages

76 tables

183 charts

5 region

18 countries

31 company

4 segments

Purchase Options

$4200.00
$4999.00
$5999.00
$2000.00

Have a question?

Please get in touch with our team in case of any queries

+1-312-235-2040

THE GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET IS EXPECTED TO REACH USD 27.74 BILLION BY 2028 FROM USD 20.39 BILLION IN 2022, GROWING AT A CAGR OF 5.26% DURING THE FORECAST PERIOD.

The Healthcare Cold Chain Logistics Market Size, Share, & Trends Analysis Report by

  • Product: Pharmaceuticals, Medical Products, and Others
  • Service: Transportation (Road, Water, and Air), Warehousing, and Others
  • End-User: Pharmaceutical/Biotech Companies, Hospitals & Clinics, Research & Diagnostic Labs, and Others
  • Geography: North America, Europe, APAC, Latin America, and Middle East & Africa

Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2023–2028.

Customize this Report

This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize

HEALTHCARE COLD CHAIN LOGISTICS MARKET REPORT SCOPE

REPORT ATTRIBUTEDETAILS
Market Size (2028)USD 27.74 Billion
Market Size (2022)USD 20.39 Billion
CAGR (2022-2028)5.26%
Base Year2022
FORECAST YEAR2023-2028
SEGMENTS BYProduct, Service, End-User, and Geography
GEOGRAPHIC ANALYSISNorth America, Europe, APAC, Latin America, and Middle East & Africa
KEY VENDORSAmerisourceBergen, DB Group, Deutsche Post DHL Group, CEVA Logistics, United Parcel Service, FedEx, and Kuehne + Nagel
Interested in this Report?

Download a Sample!

MARKET OUTLOOK

The global healthcare cold chain logistics market was valued at USD 20.39 billion in 2022 and is expected to reach USD 27.74 billion by 2028, growing at a CAGR of 5.26%. Healthcare cold chain logistics deals with manufacturing, processing, shipping materials, and resources and activities related to handling manufactured goods by customers. Logistics companies play a crucial role in the functioning of any pharmaceutical company. The growing R&D spending to develop new drugs and therapies, rising demand for generic drugs and vaccines, and clinical trial materials are the major driving factors for the growth of the healthcare cold chain logistics market. The growing ocean freight for healthcare products shipments is one of the major factors driving the market's growth.

The COVID-19 pandemic has created complexities in the global supply chain that impacted all the modes of freight transportation, from air to rail cargo, which may take months or years to get back to normal.

MARKET TRENDS

The increasing demand for air ambulances is fueled by growing demand for organ transplants and emergency patient transfer. The demand for air ambulances is growing in the U.S. and Europe; however, it is expected to create lucrative opportunities in APAC and Latin America during the forecast period. The leading healthcare cold chain logistics also raises growing funds to support air ambulances. For instance, Deutsche Post DHL Group raised about USD 95,900 in 2021 for local air ambulance service.

Recently, clinical research has become highly globalized, with many of these studies being conducted across the globe and a significant increase in clinical trials in developing countries. The focus of clinical trial researchers is now shifting from developed markets of Japan, Australia, South Korea, and Singapore to emerging economies such as Thailand, China, the Philippines, and Vietnam.

Major companies strive to offer cloud-based supply chain services and secured supply chain functions such as blockchain technology and live tracking platform as they help healthcare companies safeguard the validity of their products. Vendors in the healthcare cold chain logistics market, such as FedEx and Nippon Express, are focused on developing their pioneering IoT technology to monitor and perform the live tracking of their shipments. These solutions are also expected to prevent the production and distribution of counterfeit drugs. According to DB Schenker, a subsidiary of DB Group, to increase transport density and reliability, the shift to digital rail operations and digitalization of infrastructure and vehicles is essential. In 2019, TrakCel, one of the global leaders in managing clinical supply chain logistics, partnered with Quick Group to provide industry-leading digital supply chain IT solutions for cell and gene therapies.

The recent emergence of cell and gene therapy is expected to create lucrative opportunities for the healthcare cold chain logistics market. Healthcare cold chain logistics providers increasingly focus on delivering value-added services to hospitals and clinics.

Many pharmaceutical drugs, medicines, and specialty treatments are temperature-sensitive and require swift supply chains. Cold chain storage and distribution provide a reliable mechanism to maintain the integrity of the drug substances and products. Production of pharmaceuticals is getting more complex as companies expand their product portfolio to align with the rapidly changing market and meet customers' needs. With the increasing number of chronic disease cases, the demand for modern healthcare products and services and improved medical assistance is also rising, especially in rural areas. Consecutively, this has generated a need for the safe transportation of pharma products. Healthcare manufacturers increasingly demand specialized healthcare cold chain logistics services to deliver efficient warehousing, transporting, and distribution services for large volumes of pharmaceuticals to hospitals, home care patients, labs, and other healthcare facilities. The growing demand for temperature-controlled products, especially pharmaceutical ones, with the development of many advanced therapies derived from human cells, has evoked the need for cold chain logistics and contributed to the healthcare cold chain logistics market growth.

SEGMENTATION INSIGHTS

INSIGHTS BY PRODUCT
The pharmaceuticals product segment dominated the global healthcare cold chain logistics market due to increasing demand for both branded and generic drugs and vaccines. Pharmaceuticals are imported and exported around the world on a massive scale. Aging populations and new drugs to treat rare and specialty diseases fuel this growth. North America and Europe are the major markets for the largest pharmaceutical segment share. About 97% of marketed drugs are classified as small molecules. Biologics will lead among the top-selling products and new sales generators projected for 2022, whereas small molecules will continue to lead in new drug approvals. According to the US FDA’s Center for Drug Evaluation and Research, of the 50 new molecular entities (NMEs) approved in 2021, 36 (72%) were small molecules, and 14 (28%) were biologics.

INSIGHTS BY FUNCTION
The global healthcare cold chain logistics market by service is segmented into transportation, warehousing, and others. As transportation is a crucial part of the logistics chain, it accounted for the highest revenue share of the market. Transportation is the most crucial part of cold chain logistics because the products are transported to the end-user. The demand for temperature-controlled transportation is also rising to maintain the quality of products. Furthermore, road transportation dominates the transportation segment, with a revenue share of over 66% in 2022. The highest share of road transportation can be attributed to its low cost in workforce and operation. In January 2021, over 58% of US-Canada cross-border freight was moved by trucks, followed by rail, with over 16% of cross-border freight.

However, in 2020, European land transport declined because of the COVID-19 pandemic. Between April and August 2020, after decreased prices and falling demand, prices grew exponentially compared to levels in October 2020, and the demand increased significantly. As air rates are higher in the healthcare cold chain logistics market than water and road, the demand for logistics through the air is lowest. Further, air freight is 78% more expensive than ocean freight, and it leads the pack with 80% of all temperature excursions for pharmaceutical products transportation. In comparison, ocean transportation has a 1% temperature excursion rate, while road transport is a little higher, with 18% of all the excursions.

INSIGHTS BY END-USER
The pharmaceutical/biotech companies' end-user segment accounted for the highest revenue share of the global healthcare cold chain logistics market in 2022. Pharmaceutical/biotech companies dominate the end-user segment because this segment is the primary manufacturer of healthcare products that are temperature sensitive and need cold chain logistics to ensure efficient and timely delivery of medications to the patients and to receive raw materials such as APIs to develop several pharmaceutical products. In recent years, it has been noticed that there is growing spending in cold chain logistics that is contributing to market growth. The revenue share of the pharmaceutical/biotech companies’ segment is expected to grow faster in APAC during the forecast period as APAC is a potential market for pharma industry growth.

GEOGRAPHICAL ANALYSIS

North America accounted for the highest revenue share of over 37% of the global healthcare cold chain logistics market in 2022. The larger share is contributed by the increasing clinical trial spending, increasing spending on R&D activities to develop new drugs and the presence of top leading pharmaceutical companies. About five of the ten leading pharmaceutical companies in 2020 were from the United States. In the U.S., branded drugs accounted for around 83.9% of spending in the US alone. In 2020, about 8.1% of global drug and medicine shipments originated from North America. Further, North America and Europe accounted for about 80% of monoclonal antibodies. Thus, the demand for biologics, i.e., vaccines and monoclonal antibodies, is increasing investments in R&D. These are major factors driving the healthcare cold chain logistics market.

Europe is a major exporter of pharmaceutical drugs. For instance, Germany, Switzerland, and Ireland were the top three major exporters of pharmaceutical products in 2020. The demand for pharmaceutical logistics in Europe is driven by the growing demand for biologics, such as vaccines, propelled by the COVID-19 pandemic and growing investments from leading pharmaceutical firms. In 2019, sales of the pharmaceutical industry in the country increased by 5.7%, reaching about USD 52.1 billion. Over 500 pharmaceutical companies are in Germany. Small and mid-size enterprises (SMEs) are the backbone of the economic sector, with around 90% of drug manufacturers. In 2018, Germany generated a production value of USD 42.1 billion, making it Europe's leading pharmaceutical manufacturing country. North America and Europe are the leading countries with more organ transplants expected to create lucrative opportunities for air-based healthcare cold-chain logistics providers.

VENDOR LANDSCAPE

The global healthcare cold chain logistics market is highly fragmented and concentrated, with many key players in the industry. AmerisourceBergen, DB Group, Deutsche Post DHL Group, CEVA Logistics, United Parcel Service, FedEx, and Kuehne + Nagel are the significant players in the global healthcare cold chain logistics market. Vendors are increasingly focusing on integrating new advancements in their services to become more competitive and increase their profit margin. Some of these advancements include integrating blockchain technology to ensure safety and authenticity and avoid counterfeiting drug fraud. Further, several vendors, such as Kuehne+ Nagel, give a fully integrated “live tracking” platform for easy access to data regarding the shipment. In addition, FedEx, a key company, and Nippon Express provide safe and compliant transportation of temperature-sensitive shipments in pharma. Their shipments are enabled with real-time tracking and tracing data.

The prominent vendors also compete by offering cold chain transportation services and various warehousing services at competitive prices. However, the healthcare cold chain logistics market is highly dominated by major players, and other players are also focusing on providing low-cost logistics services to their customers. In addition, a few emerging companies are also focusing on healthcare-specific cold chain logistics services and advancing their shipment monitoring services by improving visibility. The vendors also focus more on ocean transportation to save costs, make larger shipments, and on environmentally friendly shipping.

Frequently Asked Questions

How big is the healthcare cold chain logistics market?

The global healthcare cold chain logistics market share was valued at USD 20.39 billion in 2022 and is expected to reach USD 27.74 billion by 2028.

What is the projected growth rate of the healthcare cold chain logistics market?

The healthcare cold chain logistics market is projected to grow at a CAGR of 5.26% during the forecast period.

Who are the key players in the global healthcare cold chain logistics market?

AmerisourceBergen, DB Group, Deutsche Post DHL Group, CEVA Logistics, United Parcel Service, FedEx, and Kuehne + Nagel are the key players in the global healthcare cold chain logistics market.

What are the growing trends in the healthcare cold chain logistics market?

The growing trends in the global healthcare cold chain logistics market are logistics control through the Internet of medical things, the emergence of blockchain technology, and direct-to-patient logistics services.

Which region holds the most significant global healthcare cold chain logistics market share?

North America dominated the global healthcare cold chain logistics market, accounting for over 37% in 2022.

The global healthcare cold chain logistics market size is expected to grow at a CAGR of approximately 5.26% from 2022 to 2028.

The following factors are likely to contribute to the growth of the healthcare cold chain logistics market during the forecast period:

  • Clinical Trials: A Strong and Growing Business
  • Increasing Collaborations Between 3PL Providers and Healthcare Providers
  • Rising Demand for Generics and Biosimilars
  • Rising Mass Immunization Programmes

Base Year: 2022

Forecast Year: 2023-2028

The report considers the present scenario of the healthcare cold chain logistics market and its market dynamics for 2023−2028. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.

Key Company Profiles

  • AmerisourceBergen
    • Business Overview
    • Product Offerings
    • Key Strategies
    • Key Strengths
    • Key Opportunities
  • DB Group
  • Deutsche Post DHL Group
  • CEVA Logistics
  • United Parcel Service
  • FedEx
  • Kuehne + Nagel

Other Prominent Vendors

  • AWL India
    • Business Overview
    • Service Offerings
  • Alloga
  • A.P. Moller – Maersk
  • Azenta
  • Cold Chain Technologies
  • COREX Logistics
  • Cardinal Health
  • DPD
  • DSV
  • Farmasoft
  • GXO Logistics
  • Kerry Logistics Network
  • Lufthansa Cargo
  • Logista
  • Nippon Express
  • Noatum Logistics
  • Phoenix Group
  • Parexel International
  • Quick International Courier
  • SEKO Logistics
  • SINOTRANS
  • Yourway
  • YUSEN LOGISTICS
  • YSDS

Segmentation by Product

  • Pharmaceuticals
  • Medical Products
  • Others

Segmentation by Service

  • Transportation
    • Road
    • Water
    • Air
  • Warehousing
  • Others

Segmentation by End-User

  • Pharmaceutical/Biotech Companies
  • Hospitals & Clinics
  • Research & Diagnostic Labs
  • Others

Segmentation by Geography

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • The U.K.
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • South Africa

EXHIBIT 1 SEGMENTATION OF GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET

EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2022

EXHIBIT 3 MAJOR CHALLENGES FOR GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET

EXHIBIT 4 OVERVIEW OF COLD CHAIN TECHNOLOGY

EXHIBIT 5 GLOBAL BIOPHARMACEUTICAL COLD CHAIN SPENDING ($ BILLION)

EXHIBIT 6 IMPACT OF LOGISTICS CONTROL THROUGH INTERNET OF MEDICAL THINGS (IOMT)

EXHIBIT 7 IOT-ENABLED REAL-TIME COLD CHAIN MONITORING IN CONTAINER PORT

EXHIBIT 8 IOT SPENDINGS IN TRANSPORTATION AND LOGISTICS 2015 VS 2020 ($ BILLION)

EXHIBIT 9 IMPACT OF ADOPTION OF BLOCKCHAIN TECHNOLOGY

EXHIBIT 10 IMPACT OF EMERGENCE OF DIRECT-TO-PATIENT LOGISTICS SERVICES

EXHIBIT 11 BENEFITS OF DIRECT-TO-PATIENT LOGISTICS

EXHIBIT 12 IMPACT OF RISE IN NUMBER OF CLINICAL TRIALS

EXHIBIT 13 NUMBER OF CLINICAL TRIALS PER YEAR BY INCOME GROUP 2015–2019

EXHIBIT 14 IMPACT OF INCREASING COLLABORATIONS BETWEEN 3PL PROVIDERS & HEALTHCARE PROVIDERS

EXHIBIT 15 IMPACT OF SURGE IN DEMAND FOR GENERICS AND BIOSIMILARS

EXHIBIT 16 LEADING COUNTRIES IN GENERICS MARKET (2019)

EXHIBIT 17 AGGREGATE VALUE OF GLOBAL PHARMACEUTICAL INDUSTRY 2014-2021 ($ TRILLIONS)

EXHIBIT 18 IMPACT OF INCREASE IN MASS IMMUNIZATION PROGRAMS

EXHIBIT 19 IMPACT OF LACK OF COMPLIANCE & CHANGING REGULATIONS

EXHIBIT 20 COSTS INCURRED DUE TO TEMPERATURE DEVIATIONS 2019 ($ BILLION)

EXHIBIT 21 IMPACT OF GEOPOLITICAL RISKS & FLUCTUATING INTERNATIONAL TRADE REGULATORY POLICIES

EXHIBIT 22 IMPACT OF INBOUND LOGISTICS SERVICES FOR MANUFACTURERS

EXHIBIT 23 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 24 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT 2022 & 2028 (%)

EXHIBIT 25 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022 & 2028 (%)

EXHIBIT 26 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER 2022 & 2028 (%)

EXHIBIT 27 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY GEOGRAPHY 2022 & 2028 (%)

EXHIBIT 28 FIVE FORCES ANALYSIS 2022

EXHIBIT 29 INCREMENTAL GROWTH BY PRODUCT 2022 & 2028

EXHIBIT 30 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT

EXHIBIT 31 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT: INCREMENTAL GROWTH ($ BILLION)

EXHIBIT 32 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT: ABSOLUTE GROWTH ($ BILLION)

EXHIBIT 33 PHASE I-IV OF GLOBAL CLINICAL TRIALS SPENDING, DRUGS, AND BIOLOGICALS ($ BILLION)

EXHIBIT 34 NUMBER OF BIOLOGICS APPROVED AS NMES BY FDA 2017–2021

EXHIBIT 35 GLOBAL SALES OF TOP MABS 2019 ($ BILLION)

EXHIBIT 36 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PHARMACEUTICALS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 37 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PHARMACEUTICALS 2022–2028 ($ BILLION)

EXHIBIT 38 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028

EXHIBIT 39 GROSS DOMESTIC SPENDING ON R&D (TOTAL PERCENTAGE OF GDP) 2016–2021

EXHIBIT 40 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY MEDICAL PRODUCTS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 41 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY MEDICAL PRODUCTS 2022–2028 ($ BILLION)

EXHIBIT 42 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028

EXHIBIT 43 ADVANTAGES OF AIR AMBULANCE IN HEALTHCARE

EXHIBIT 44 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY OTHER PRODUCTS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 45 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY OTHER PRODUCTS 2022–2028 ($ BILLION)

EXHIBIT 46 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028

EXHIBIT 47 INCREMENTAL GROWTH BY SERVICE 2022 & 2028

EXHIBIT 48 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE

EXHIBIT 49 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE: INCREMENTAL GROWTH ($ BILLION)

EXHIBIT 50 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE: ABSOLUTE GROWTH ($ BILLION)

EXHIBIT 51 OVERVIEW OF COMMON COLD CHAINS

EXHIBIT 52 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY TRANSPORTATION: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 53 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY TRANSPORTATION 2022–2028 ($ BILLION)

EXHIBIT 54 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028

EXHIBIT 55 ADVANTAGES OF OVER-THE-ROAD TRANSPORTATION

EXHIBIT 56 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY ROAD TRANSPORTATION 2022–2028 ($ BILLION)

EXHIBIT 57 ADVANTAGES OF OCEAN TRANSPORTATION

EXHIBIT 58 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY WATER TRANSPORTATION 2022–2028 ($ BILLION)

EXHIBIT 59 ADVANTAGES OF AIR TRANSPORTATION

EXHIBIT 60 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY AIR TRANSPORTATION 2022–2028 ($ BILLION)

EXHIBIT 61 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY WAREHOUSING: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 62 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY WAREHOUSING 2022–2028 ($ BILLION)

EXHIBIT 63 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028

EXHIBIT 64 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY OTHER SERVICES: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 65 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY OTHER SERVICES 2022–2028 ($ BILLION)

EXHIBIT 66 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028

EXHIBIT 67 INCREMENTAL GROWTH BY END USER 2022 & 2028

EXHIBIT 68 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER

EXHIBIT 69 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER: INCREMENTAL GROWTH ($ BILLION)

EXHIBIT 70 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER: ABSOLUTE GROWTH ($ BILLION)

EXHIBIT 71 COLD CHAIN LOGISTICS SPENDING IN PHARMACEUTICALS ($ BILLION)

EXHIBIT 72 WORLD’S BIGGEST PLAYERS RANKED BY PRESCRIPTION DRUG SALES 2021 ($ BILLION)

EXHIBIT 73 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PHARMACEUTICAL/BIOTECHNOLOGY COMPANIES: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 74 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 75 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028

EXHIBIT 76 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY HOSPITALS AND CLINICS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 77 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 78 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028

EXHIBIT 79 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY RESEARCH AND DIAGNOSTIC LABS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 80 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 81 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028

EXHIBIT 82 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY OTHER END USERS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 83 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY OTHER END USERS 2022–2028 ($ BILLION)

EXHIBIT 84 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028

EXHIBIT 85 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028

EXHIBIT 86 TOP EXPORTERS OF PHARMACEUTICAL PRODUCTS WORLDWIDE 2020 ($ BILLION)

EXHIBIT 87 GEOGRAPHICAL SEGMENTATION OF SALES OF NEW MEDICINES LAUNCHED 2015–2020 (%)

EXHIBIT 88 PHARMACEUTICAL R&D EXPENDITURE: ANNUAL GROWTH RATE 2006–2020 (%)

EXHIBIT 89 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH ($ BILLION)

EXHIBIT 90 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH ($ BILLION)

EXHIBIT 91 PERCENTAGE OF API MANUFACTURING FACILITIES FOR ALL DRUGS BY COUNTRY OR REGION AUGUST 2019

EXHIBIT 92 NORTH AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET: KEY COUNTRIES 2022 ($ BILLION)

EXHIBIT 93 NORTH AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 94 NORTH AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 95 INCREMENTAL GROWTH BY PRODUCT 2022 & 2028

EXHIBIT 96 INCREMENTAL GROWTH BY SERVICE 2022 & 2028

EXHIBIT 97 INCREMENTAL GROWTH BY END USER 2022 & 2028

EXHIBIT 98 INCREMENTAL GROWTH IN NORTH AMERICA 2022 & 2028

EXHIBIT 99 US PHARMACEUTICAL SALES 2017–2021 ($ BILLION)

EXHIBIT 100 US HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 101 PERCENTAGE OF BIOLOGIC SPENDING ON BIOSIMILARS 2019–2021

EXHIBIT 102 SALES OF PATENTED AND NON-PATENTED DRUGS BY CANADIAN MANUFACTURERS 2011–2019 ($ BILLION)

EXHIBIT 103 HEALTH EXPENDITURE OF CANADIANS 2011–2019 ($ BILLION)

EXHIBIT 104 IMPORTS AND EXPORTS OF PHARMACEUTICAL AND MEDICINAL PRODUCTS NOVEMBER 2019–NOVEMBER 2021 ($ MILLION)

EXHIBIT 105 CANADA HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 106 EUROPEAN PHARMACEUTICAL MANUFACTURING VALUE 2019 ($ MILLION)

EXHIBIT 107 EUROPE HEALTHCARE COLD CHAIN LOGISTICS MARKET: KEY COUNTRIES 2022 ($ BILLION)

EXHIBIT 108 EUROPE HEALTHCARE COLD CHAIN LOGISTICS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 109 EUROPE HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 110 INCREMENTAL GROWTH BY PRODUCT 2022 & 2028

EXHIBIT 111 INCREMENTAL GROWTH BY SERVICE 2022 & 2028

EXHIBIT 112 INCREMENTAL GROWTH BY END USER 2022 & 2028

EXHIBIT 113 INCREMENTAL GROWTH IN EUROPE 2022 & 2028

EXHIBIT 114 TOTAL DRUG SALES IN GERMAN PHARMACY MARKET 2019 (MILLION PACKAGING UNITS)

EXHIBIT 115 PHARMACEUTICAL PRODUCTION IN GERMANY 2015–2018 ($ BILLION)

EXHIBIT 116 EXPORT OF PHARMACEUTICALS FROM GERMANY ($ BILLION)

EXHIBIT 117 GERMANY HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 118 SALES REVENUE OF OTC PHARMACEUTICALS 2017–2021 ($ MILLION)

EXHIBIT 119 FRANCE HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 120 GROWTH OF PHARMACEUTICAL WHOLESALE IN UK 2016–2021

EXHIBIT 121 KEY INSIGHTS INTO UK PHARMACEUTICAL INDUSTRY

EXHIBIT 122 UK HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 123 ITALY HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 124 TOTAL REVENUE FROM OTC PHARMACEUTICALS IN SPAIN 2017–2021

EXHIBIT 125 SPAIN HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 126 PHARMACEUTICAL SPENDING BY APAC COUNTRIES 2018 ($ BILLION)

EXHIBIT 127 APAC HEALTHCARE COLD CHAIN LOGISTICS MARKET: KEY COUNTRIES 2022 ($ BILLION)

EXHIBIT 128 APAC HEALTHCARE COLD CHAIN LOGISTICS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 129 APAC HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 130 INCREMENTAL GROWTH BY PRODUCT 2022 & 2028

EXHIBIT 131 INCREMENTAL GROWTH BY SERVICE 2022 & 2028

EXHIBIT 132 INCREMENTAL GROWTH BY END USER 2022 & 2028

EXHIBIT 133 INCREMENTAL GROWTH IN APAC 2022 & 2028

EXHIBIT 134 REVENUE SEGMENTATION OF CHINESE PHARMACEUTICAL INDUSTRY 2018 ($ BILLION)

EXHIBIT 135 TOTAL PHARMACEUTICAL COLD CHAIN LOGISTICS COST OF CHINA 2018–2021

EXHIBIT 136 CHINA HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 137 JAPAN HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 138 BIOSIMILARS APPROVED BY COUNTRY AND REGION 2019

EXHIBIT 139 INTERNATIONAL TRADE (EXPORT) IN PHARMACEUTICALS ($ BILLION)

EXHIBIT 140 DRUG AND PHARMACEUTICAL EXPORT TREND IN INDIA ($ BILLION)

EXHIBIT 141 MEDICINAL DRUG EXPORTS BY INDIA (2021–2022)

EXHIBIT 142 INDIA HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 143 DRUG EXPENDITURE DYNAMICS 1995–2020

EXHIBIT 144 SOUTH KOREA HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 145 AUSTRALIA HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 146 LATIN AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET: KEY COUNTRIES 2022 ($ BILLION)

EXHIBIT 147 LATIN AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 148 LATIN AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 149 INCREMENTAL GROWTH BY PRODUCT 2022 & 2028

EXHIBIT 150 INCREMENTAL GROWTH BY SERVICE 2022 & 2028

EXHIBIT 151 INCREMENTAL GROWTH BY END-USER 2022 & 2028

EXHIBIT 152 INCREMENTAL GROWTH IN LATIN AMERICA 2022 & 2028

EXHIBIT 153 BRAZIL HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 154 MEXICO HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 155 SHARE OF IMPORTS AND LOCAL PRODUCTION 2020

EXHIBIT 156 SALES IN ARGENTINE PHARMACEUTICAL INDUSTRY 2017-2021 ($ BILLION)

EXHIBIT 157 OTC SALES IN ARGENTINE PHARMACEUTICAL INDUSTRY 2017−2020 (%)

EXHIBIT 158 PHARMACEUTICAL EXPORTS AND IMPORTS IN ARGENTINA 2017−2021 ($ BILLION)

EXHIBIT 159 ARGENTINA HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 160 MIDDLE EAST & AFRICA HEALTHCARE COLD CHAIN LOGISTICS MARKET: KEY COUNTRIES 2022 ($ BILLION)

EXHIBIT 161 MIDDLE EAST & AFRICA HEALTHCARE COLD CHAIN LOGISTICS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 162 MIDDLE EAST AND AFRICA HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 163 INCREMENTAL GROWTH BY PRODUCT 2022 & 2028

EXHIBIT 164 INCREMENTAL GROWTH BY SERVICE 2022 & 2028

EXHIBIT 165 INCREMENTAL GROWTH BY END-USER 2022 & 2028

EXHIBIT 166 INCREMENTAL GROWTH IN MIDDLE EAST AND AFRICA 2022 & 2028

EXHIBIT 167 SHARE OF BIOSIMILARS BY THERAPEUTIC AREAS 2020 (%)

EXHIBIT 168 TURKEY PHARMACEUTICALS MARKET COMPOSITION 2019 ($ BILLION)

EXHIBIT 169 TURKEY PHARMACEUTICALS MARKET COMPOSITION 2019 ($ BILLION)

EXHIBIT 170 TURKEY HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 171 SAUDI ARABIA PHARMACEUTICALS MARKET COMPOSITION 2019 ($ BILLION)

EXHIBIT 172 SAUDI ARABIA HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 173 SOUTH AFRICA HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)

EXHIBIT 174 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET: CAPABILITIES & EXPERTISE ASSESSMENT

EXHIBIT 175 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET: MARKET DOMINANT ANALYSIS

EXHIBIT 176 AMERISOURCEBERGEN: TOTAL REVENUE 2019–2021 ($ MILLION)

EXHIBIT 177 DB GROUP: TOTAL REVENUE 2019–2021 ($ BILLION)

EXHIBIT 178 DB GROUP: DG SCHENKER SUBSIDIARY REVENUE 2019–2021 ($ BILLION)

EXHIBIT 179 DB GROUP: NET CAPITAL EXPENDITURE 2019–2021 ($ BILLION)

EXHIBIT 180 DEUTSCHE POST DHL GROUP: TOTAL REVENUE 2019-2021 ($ BILLION)

EXHIBIT 181 FEDEX: TOTAL REVENUE 2019–2021 ($ BILLION)

EXHIBIT 182 FEDEX: MAJOR SERVICE OFFERINGS

EXHIBIT 183 KUEHNE + NAGEL: TOTAL REVENUE 2019–2021 ($ BILLION)

 

LIST OF TABLES

TABLE 1 KEY CAVEATS

TABLE 2 CURRENCY CONVERSION 2016−2022

TABLE 3 PERCENTAGE SHARE OF VARIOUS BIOPHARMACEUTICALS (2015–2020)

TABLE 4 PERCENTAGE SHARE OF VARIOUS BIOPHARMACEUTICALS BETWEEN 2015 AND 2020

TABLE 5 BABY IMMUNIZATION SCHEDULE (BASED ON IAPCOI RECOMMENDATIONS)

TABLE 6 TOP SIX BEST-SELLING COVID-19 VACCINES 2021 ($ BILLION)

TABLE 7 NUMBER OF ORGANS TRANSPLANTED IN 2018 (IN 28 EU COUNTRIES WITH 509.7 MILLION INHABITANTS)

TABLE 8 TOTAL PHARMACEUTICALS MARKET ($ THOUSANDS), 2017−2020

TABLE 9 AMERISOURCEBERGEN: MAJOR SERVICE OFFERINGS

TABLE 10 DB SCHENKER: MAJOR SERVICE OFFERINGS

TABLE 11 DEUTSCHE POST DHL GROUP: MAJOR SERVICE OFFERINGS

TABLE 12 CEVA LOGISTICS: MAJOR SERVICE OFFERINGS

TABLE 13 UNITED PARCEL SERVICE: MAJOR SERVICE OFFERINGS

TABLE 14 KUEHNE + NAGEL: MAJOR SERVICE OFFERINGS

TABLE 15 AWL INDIA: MAJOR SERVICE OFFERINGS

TABLE 16 ALLOGA: MAJOR SERVICE OFFERINGS

TABLE 17 A.P. MOLLER - MAERSK: MAJOR SERVICE OFFERINGS

TABLE 18 AZENTA: MAJOR PRODUCT OFFERINGS

TABLE 19 COLD CHAIN TECHNOLOGIES: MAJOR SERVICE OFFERINGS

TABLE 20 COREX LOGISTICS: MAJOR SERVICE OFFERINGS

TABLE 21 CARDINAL HEALTH: MAJOR SERVICE OFFERINGS

TABLE 22 DPD: MAJOR SERVICE OFFERINGS

TABLE 23 DSV: MAJOR SERVICE OFFERINGS

TABLE 24 FARMASOFT: MAJOR SERVICE OFFERINGS

TABLE 25 GXO LOGISTICS: MAJOR SERVICE OFFERINGS

TABLE 26 KERRY LOGISTICS NETWORK: MAJOR PRODUCT OFFERINGS

TABLE 27 LUFTHANSA CARGO: MAJOR SERVICE OFFERINGS

TABLE 28 LOGISTA: MAJOR PRODUCT OFFERINGS

TABLE 29 NIPPON EXPRESS: MAJOR SERVICE OFFERINGS

TABLE 30 NOATUM LOGISTICS: MAJOR SERVICE OFFERINGS

TABLE 31 PHOENIX GROUP: MAJOR SERVICE OFFERINGS

TABLE 32 PAREXEL INTERNATIONAL: MAJOR SERVICE OFFERINGS

TABLE 33 QUICK INTERNATIONAL COURIER: MAJOR PRODUCT OFFERINGS

TABLE 34 SEKO LOGISTICS: MAJOR SERVICE OFFERINGS

TABLE 35 SINOTRANS: MAJOR SERVICE OFFERINGS

TABLE 36 YOURWAY: MAJOR SERVICE OFFERINGS

TABLE 37 YUSEN LOGISTICS: MAJOR SERVICE OFFERINGS

TABLE 38 YSDS: MAJOR PRODUCT OFFERINGS

TABLE 39 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)

TABLE 40 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY GEOGRAPHY 2022–2028 (%)

TABLE 41 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT 2022–2028 ($ BILLION)

TABLE 42 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT 2022–2028 (%)

TABLE 43 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022–2028 ($ BILLION)

TABLE 44 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022–2028 (%)

TABLE 45 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER 2022–2028 ($ BILLION)

TABLE 46 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022–2028 (%)

TABLE 47 NORTH AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT 2022–2028 ($ BILLION)

TABLE 48 NORTH AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT 2022–2028 (%)

TABLE 49 NORTH AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022–2028 ($ BILLION)

TABLE 50 NORTH AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022–2028 (%)

TABLE 51 NORTH AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER 2022–2028 ($ BILLION)

TABLE 52 NORTH AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER 2022–2028 (%)

TABLE 53 EUROPE HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT 2022–2028 ($ BILLION)

TABLE 54 EUROPE HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT 2022–2028 (%)

TABLE 55 EUROPE HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022–2028 ($ BILLION)

TABLE 56 EUROPE HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022–2028 (%)

TABLE 57 EUROPE HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER 2022–2028 ($ BILLION)

TABLE 58 EUROPE HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER 2022–2028 (%)

TABLE 59 APAC HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT 2022–2028 ($ BILLION)

TABLE 60 APAC HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT 2022–2028 (%)

TABLE 61 APAC HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022–2028 ($ BILLION)

TABLE 62 APAC HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022–2028 (%)

TABLE 63 APAC HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER 2022–2028 ($ BILLION)

TABLE 64 APAC HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER 2022–2028 (%)

TABLE 65 LATIN AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT 2022–2028 ($ BILLION)

TABLE 66 LATIN AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT 2022–2028 (%)

TABLE 67 LATIN AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022–2028 ($ BILLION)

TABLE 68 LATIN AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022–2028 (%)

TABLE 69 LATIN AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER 2022–2028 ($ BILLION)

TABLE 70 LATIN AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER 2022–2028 (%)

TABLE 71 MIDDLE EAST AND AFRICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT 2022–2028 ($ BILLION)

TABLE 72 MIDDLE EAST AND AFRICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT 2022–2028 (%)

TABLE 73 MIDDLE EAST AND AFRICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022–2028 ($ BILLION)

TABLE 74 MIDDLE EAST AND AFRICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022–2028 (%)

TABLE 75 MIDDLE EAST AND AFRICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER 2022–2028 ($ BILLION)

TABLE 76 MIDDLE EAST AND AFRICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER 2022–2028 (%)

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

 

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 EXCLUSIONS

4.1.3 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.2 MARKET SEGMENTATION BY PRODUCT

4.3.3 MARKET SEGMENTATION BY FUNCTION

4.3.4 MARKET SEGMENTATION BY FUNCTION

4.3.5 MARKET SEGMENTATION BY GEOGRAPHY

 

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

 

6 PREMIUM INSIGHTS

6.1 MARKET SCENARIO

 

7 MARKET AT A GLANCE

8 INTRODUCTION

8.1 OVERVIEW

9 MARKET OPPORTUNITIES & TRENDS

9.1 LOGISTICS CONTROL THROUGH INTERNET OF MEDICAL THINGS (IOMT)

9.2 ADOPTION OF BLOCKCHAIN TECHNOLOGY

9.3 EMERGENCE OF DIRECT-TO-PATIENT LOGISTICS SERVICES

 

10 MARKET GROWTH ENABLERS

10.1 RISE IN NUMBER OF CLINICAL TRIALS

10.2 INCREASING COLLABORATIONS BETWEEN  3PL PROVIDERS & HEALTHCARE PROVIDERS

10.3 SURGE IN DEMAND FOR GENERICS & BIOSIMILARS

10.4 INCREASE IN MASS IMMUNIZATION PROGRAMS

 

11 MARKET RESTRAINTS

11.1 LACK OF COMPLIANCE & CHANGING REGULATIONS

11.2 GEOPOLITICAL RISKS & FLUCTUATING INTERNATIONAL TRADE REGULATORY POLICIES

11.3 INBOUND LOGISTICS SERVICES FOR MANUFACTURERS

 

12 MARKET LANDSCAPE

12.1 MARKET OVERVIEW

12.2 MARKET SIZE & FORECAST

12.2.1 INSIGHTS BY PRODUCT

12.2.2 INSIGHTS BY SERVICE

12.2.3 INSIGHTS BY END USER

12.2.4 INSIGHTS BY GEOGRAPHY

12.3 FIVE FORCES ANALYSIS

12.3.1 THREAT OF NEW ENTRANTS

12.3.2 BARGAINING POWER OF SUPPLIERS

12.3.3 BARGAINING POWER OF BUYERS

12.3.4 THREAT OF SUBSTITUTES

12.3.5 COMPETITIVE RIVALRY

 

13 PRODUCT

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

13.3 PHARMACEUTICALS

13.3.1 MARKET OVERVIEW

13.3.2 MARKET SIZE & FORECAST

13.3.3 MARKET BY GEOGRAPHY

13.4 MEDICAL PRODUCTS

13.4.1 MARKET OVERVIEW

13.4.2 MARKET SIZE & FORECAST

13.4.3 MARKET BY GEOGRAPHY

13.5 OTHERS

13.5.1 MARKET OVERVIEW

13.5.2 MARKET SIZE & FORECAST

13.5.3 MARKET BY GEOGRAPHY

 

14 SERVICE

14.1 MARKET SNAPSHOT & GROWTH ENGINE

14.2 MARKET OVERVIEW

14.3 TRANSPORTATION

14.3.1 MARKET OVERVIEW

14.3.2 MARKET SIZE & FORECAST

14.3.3 MARKET BY GEOGRAPHY

14.3.4 ROAD

14.3.5 MARKET OVERVIEW

14.3.6 MARKET SIZE & FORECAST

14.3.7 WATER

14.3.8 MARKET OVERVIEW

14.3.9 MARKET SIZE & FORECAST

14.3.10 AIR

14.3.11 MARKET OVERVIEW

14.3.12 MARKET SIZE & FORECAST

14.4 WAREHOUSING

14.4.1 MARKET OVERVIEW

14.4.2 MARKET SIZE & FORECAST

14.4.3 MARKET BY GEOGRAPHY

14.5 OTHERS

14.5.1 MARKET OVERVIEW

14.5.2 MARKET SIZE & FORECAST

14.5.3 MARKET BY GEOGRAPHY

 

15 END USER

15.1 MARKET SNAPSHOT & GROWTH ENGINE

15.2 MARKET OVERVIEW

15.3 PHARMACEUTICAL/BIOTECHNOLOGY COMPANIES

15.3.1 MARKET OVERVIEW

15.3.2 MARKET SIZE & FORECAST

15.3.3 MARKET BY GEOGRAPHY

15.4 HOSPITALS & CLINICS

15.4.1 MARKET OVERVIEW

15.4.2 MARKET SIZE & FORECAST

15.4.3 MARKET BY GEOGRAPHY

15.5 RESEARCH & DIAGNOSTIC LABORATORIES

15.5.1 MARKET OVERVIEW

15.5.2 MARKET SIZE & FORECAST

15.5.3 MARKET BY GEOGRAPHY

15.6 OTHERS

15.6.1 MARKET OVERVIEW

15.6.2 MARKET SIZE & FORECAST

15.6.3 MARKET BY GEOGRAPHY

 

16 GEOGRAPHY

16.1 MARKET SNAPSHOT & GROWTH ENGINE

16.2 GEOGRAPHIC OVERVIEW

 

17 NORTH AMERICA

17.1 MARKET OVERVIEW

17.2 MARKET SIZE & FORECAST

17.3 NORTH AMERICA: PRODUCT

17.4 NORTH AMERICA: SERVICE

17.5 NORTH AMERICA: END USER

17.6 KEY COUNTRIES

17.6.1 US: MARKET SIZE & FORECAST

17.6.2 CANADA: MARKET SIZE & FORECAST

 

18 EUROPE

18.1 MARKET OVERVIEW

18.2 MARKET SIZE & FORECAST

18.3 EUROPE: PRODUCT

18.4 EUROPE: SERVICE

18.5 EUROPE: END USER

18.6 KEY COUNTRIES

18.6.1 GERMANY: MARKET SIZE & FORECAST

18.6.2 FRANCE: MARKET SIZE & FORECAST

18.6.3 UK: MARKET SIZE & FORECAST

18.6.4 ITALY: MARKET SIZE & FORECAST

18.6.5 SPAIN: MARKET SIZE & FORECAST

 

19 APAC

19.1 MARKET OVERVIEW

19.2 MARKET SIZE & FORECAST

19.3 APAC: PRODUCT

19.4 APAC: SERVICE

19.5 APAC: END USER

19.6 KEY COUNTRIES

19.6.1 CHINA: MARKET SIZE & FORECAST

19.6.2 JAPAN: MARKET SIZE & FORECAST

19.6.3 INDIA: MARKET SIZE & FORECAST

19.6.4 SOUTH KOREA: MARKET SIZE & FORECAST

19.6.5 AUSTRALIA: MARKET SIZE & FORECAST

 

20 LATIN AMERICA

20.1 MARKET OVERVIEW

20.2 MARKET SIZE & FORECAST

20.3 LATIN AMERICA: PRODUCT

20.4 LATIN AMERICA: SERVICE

20.5 LATIN AMERICA: END USER

20.6 KEY COUNTRIES

20.6.1 BRAZIL: MARKET SIZE & FORECAST

20.6.2 MEXICO: MARKET SIZE & FORECAST

20.6.3 ARGENTINA: MARKET SIZE & FORECAST

 

21 MIDDLE EAST & AFRICA

21.1 MARKET OVERVIEW

21.2 MARKET SIZE & FORECAST

21.3 MIDDLE EAST & AFRICA: PRODUCT

21.4 MIDDLE EAST & AFRICA: SERVICE

21.5 MIDDLE EAST & AFRICA: END-USER

21.6 KEY COUNTRIES

21.6.1 TURKEY: MARKET SIZE & FORECAST

21.6.2 SAUDI ARABIA: MARKET SIZE & FORECAST

21.6.3 SOUTH AFRICA: MARKET SIZE & FORECAST

 

22 COMPETITIVE LANDSCAPE

22.1 COMPETITION OVERVIEW

22.1.1 AMERISOURCEBERGEN

22.1.2 DB GROUP

22.1.3 DEUTSCHE POST DHL

22.1.4 CEVA LOGISTICS

22.1.5 UNITED PARCEL SERVICE

22.1.6 FEDEX

22.1.7 KUEHNE+NAGEL

 

23 KEY COMPANY PROFILES

23.1 AMERISOURCEBERGEN

23.1.1 BUSINESS OVERVIEW

23.1.2 SERVICE OFFERINGS

23.1.3 KEY STRATEGIES

23.1.4 KEY STRENGTHS

23.1.5 KEY OPPORTUNITIES

23.2 DB GROUP

23.2.1 BUSINESS OVERVIEW

23.2.2 SERVICE OFFERINGS

23.2.3 KEY STRATEGIES

23.2.4 KEY STRENGTHS

23.2.5 KEY OPPORTUNITIES

23.3 DEUTSCHE POST DHL GROUP

23.3.1 BUSINESS OVERVIEW

23.3.2 SERVICE OFFERINGS

23.3.3 KEY STRATEGIES

23.3.4 KEY STRENGTHS

23.3.5 KEY OPPORTUNITIES

23.4 CEVA LOGISTICS

23.4.1 BUSINESS OVERVIEW

23.4.2 SERVICE OFFERINGS

23.4.3 KEY STRATEGIES

23.4.4 KEY STRENGTHS

23.4.5 KEY OPPORTUNITIES

23.5 UNITED PARCEL SERVICE

23.5.1 BUSINESS OVERVIEW

23.5.2 SERVICE OFFERINGS

23.5.3 KEY STRATEGIES

23.5.4 KEY STRENGTHS

23.5.5 KEY OPPORTUNITIES

23.6 FEDEX

23.6.1 BUSINESS OVERVIEW

23.6.2 SERVICE OFFERINGS

23.6.3 KEY STRATEGIES

23.6.4 KEY STRENGTHS

23.6.5 KEY OPPORTUNITIES

23.7 KUEHNE + NAGEL

23.7.1 BUSINESS OVERVIEW

23.7.2 SERVICE OFFERINGS

23.7.3 KEY STRATEGIES

23.7.4 KEY STRENGTHS

23.7.5 KEY OPPORTUNITIES

 

24 OTHER PROMINENT VENDORS

24.1 AWL INDIA

24.1.1 BUSINESS OVERVIEW

24.1.2 SERVICE OFFERINGS

24.2 ALLOGA

24.2.1 BUSINESS OVERVIEW

24.2.2 SERVICE OFFERINGS

24.3 A.P. MOLLER - MAERSK

24.3.1 BUSINESS OVERVIEW

24.3.2 SERVICE OFFERINGS

24.4 AZENTA

24.4.1 BUSINESS OVERVIEW

24.4.2 PRODUCT OFFERINGS

24.5 COLD CHAIN TECHNOLOGIES

24.5.1 BUSINESS OVERVIEW

24.5.2 SERVICE OFFERINGS

24.6 COREX LOGISTICS

24.6.1 BUSINESS OVERVIEW

24.6.2 SERVICE OFFERINGS

24.7 CARDINAL HEALTH

24.7.1 BUSINESS OVERVIEW

24.7.2 SERVICE OFFERINGS

24.8 DPD

24.8.1 BUSINESS OVERVIEW

24.8.2 SERVICE OFFERINGS

24.9 DSV

24.9.1 BUSINESS OVERVIEW

24.9.2 SERVICE OFFERINGS

24.10 FARMASOFT

24.10.1 BUSINESS OVERVIEW

24.10.2 SERVICE OFFERINGS

24.11 GXO LOGISTICS

24.11.1 BUSINESS OVERVIEW

24.11.2 SERVICE OFFERINGS

24.12 KERRY LOGISTICS NETWORK

24.12.1 BUSINESS OVERVIEW

24.12.2 PRODUCT OFFERINGS

24.13 LUFTHANSA CARGO

24.13.1 BUSINESS OVERVIEW

24.13.2 SERVICE OFFERINGS

24.14 LOGISTA

24.14.1 BUSINESS OVERVIEW

24.14.2 PRODUCT OFFERINGS

24.15 NIPPON EXPRESS

24.15.1 BUSINESS OVERVIEW

24.15.2 SERVICE OFFERINGS

24.16 NOATUM LOGISTICS

24.16.1 BUSINESS OVERVIEW

24.16.2 SERVICE OFFERINGS

24.17 PHOENIX GROUP

24.17.1 BUSINESS OVERVIEW

24.17.2 SERVICE OFFERINGS

24.18 PAREXEL INTERNATIONAL

24.18.1 BUSINESS OVERVIEW

24.18.2 SERVICE OFFERINGS

24.19 QUICK INTERNATIONAL COURIER

24.19.1 BUSINESS OVERVIEW

24.19.2 PRODUCT OFFERINGS

24.20 SEKO LOGISTICS

24.20.1 BUSINESS OVERVIEW

24.20.2 SERVICE OFFERINGS

24.21 SINOTRANS

24.21.1 BUSINESS OVERVIEW

24.21.2 SERVICE OFFERINGS

24.22 YOURWAY

24.22.1 BUSINESS OVERVIEW

24.22.2 SERVICE OFFERINGS

24.23 YUSEN LOGISTICS

24.23.1 BUSINESS OVERVIEW

24.23.2 SERVICE OFFERINGS

24.24 YSDS

24.24.1 BUSINESS OVERVIEW

24.24.2 PRODUCT OFFERINGS

 

25 REPORT SUMMARY

25.1 KEY TAKEAWAYS

25.2 STRATEGIC RECOMMENDATIONS

 

26 QUANTITATIVE SUMMARY

26.1 MARKET BY GEOGRAPHY

26.2 MARKET BY PRODUCT

26.3 MARKET BY SERVICE

26.4 MARKET BY END USER

26.5 NORTH AMERICA BY PRODUCT

26.6 NORTH AMERICA BY SERVICE

26.7 NORTH AMERICA BY END USER

26.8 EUROPE BY PRODUCT

26.9 EUROPE BY SERVICE

26.10 EUROPE BY END USER

26.11 APAC BY PRODUCT

26.12 APAC BY SERVICE

26.13 APAC BY END USER

26.14 LATIN AMERICA BY PRODUCT

26.15 LATIN AMERICA BY SERVICE

26.16 LATIN AMERICA BY END USER

26.17 MIDDLE EAST AND AFRICA BY PRODUCT

26.18 MIDDLE EAST AND AFRICA BY SERVICE

26.19 MIDDLE EAST AND AFRICA BY END USER

 

27 APPENDIX

27.1 ABBREVIATIONS

Select a license type that suits your business needs

Single User Licence

$4200.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email

5 User Licence

$4999.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Corporate Licence

$5999.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Datasheet Licence

$2000.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Frequently Asked Questions

How big is the healthcare cold chain logistics market?

The global healthcare cold chain logistics market share was valued at USD 20.39 billion in 2022 and is expected to reach USD 27.74 billion by 2028.

What is the projected growth rate of the healthcare cold chain logistics market?

The healthcare cold chain logistics market is projected to grow at a CAGR of 5.26% during the forecast period.

Who are the key players in the global healthcare cold chain logistics market?

AmerisourceBergen, DB Group, Deutsche Post DHL Group, CEVA Logistics, United Parcel Service, FedEx, and Kuehne + Nagel are the key players in the global healthcare cold chain logistics market.

What are the growing trends in the healthcare cold chain logistics market?

The growing trends in the global healthcare cold chain logistics market are logistics control through the Internet of medical things, the emergence of blockchain technology, and direct-to-patient logistics services.

Which region holds the most significant global healthcare cold chain logistics market share?

North America dominated the global healthcare cold chain logistics market, accounting for over 37% in 2022.